Clinical Trials Logo

Cancer of the Bile Duct clinical trials

View clinical trials related to Cancer of the Bile Duct.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02115542 Completed - Clinical trials for Cancer of the Bile Duct

Single Agent Regorafenib in Refractory Advanced Biliary Cancers

Start date: June 5, 2014
Phase: Phase 2
Study type: Interventional

The main purpose of this study is to see if regorafenib can help control or decrease cancer size in patients with cancer of the bile duct. Researchers also want to find out if regorafenib is safe and tolerable.